Q
In January 2025, you said that latest diabetes and weight reduction medicines, called GLP -1 drugs, reduce the chance of many major diseases. Do they still look so optimistic?
P. Even more. In March 2025, a serious latest research appeared within the journal Medicine. The study consisted of about a million individuals with diabetes who took either GLP-4 or other diabetes medicines and followed them for a few decade. Compared to those that didn’t take GLP-4, those that had heart failure, cardiac grip, lung failure, and pneumonia, and Alzheimer's disease and other varieties of dementia were reduced by 10 % to twenty %. Like any medicines, some people face negative effects, including stomach upset, joint pain and low blood pressure, but they were occasionally and comparatively mille. Since these GLP-4 have been available for under just a few years, we still have no idea that long-term use will show extra negative effects.
But this study and others proceed to point the importance of inflammation in lots of major diseases connecting medicines with less inflammation.
Photo: © June Chelcoom
/Getty Images
